In vitro and preventative field evaluations of potential biological control agents and synthetic fungicides for control of Clarireedia jacksonii sp. nov.
Published on: 6th February, 2020
OCLC Number/Unique Identifier: 8537104274
Clarireedia jacksonii sp. nov. Formerly Sclerotinia homoeocarpa F.T. Bennett, the causal agent of dollar spot (DS), is the most destructive pathogen in turfgrass. Symptoms appear as circular patches 10-40 mm in diameter with small tan lesions surrounded by a darker band, sometimes presenting an hour glass appearance. A multi-year study was initiated with the objective of determining the efficacy of biological control agents (BCA) and tank mixes of BCA’s and synthetic fungicides on DS control. Nutrient source was also evaluated to determine any interaction with the BCA’s and tank mixes. in vitro studies evaluated the efficacy of synthetic and BCA’s for C. jacksonii control. Quarter strength potato dextrose agar was amended with ¼, ½ and full labeled rates of various products. Chlorothalonil at all rates provided greatest (> 90%) control of C. jacksonii for study duration. Biological control agents provided best efficacy at ¼ and ½ label rates. Streptomyces griseoviridis provided least efficacy and may have exacerbated formation of C. jacksonii. Preventative field evaluations for synthetic and BCA’s provided different results between two study years. In Year 1, all treatments had < 15% disease severity for the duration of the study. In year 2, disease pressure was extremely elevated. Synthetic program 1, centered on azoxystrobin + propiconazole applications and conventional fertility sources, provided best results with < 5% disease severity for the duration of the study. Reduced synthetic program 1, and synthetic program 2 followed closely with < 10% disease severity. Reduced synthetic programs were based on monthly applications of either chlorothalonil or pyraclostrobin every 30 day, alternated with biofungicide applications. Synthetic program 2 utilized rotation applications of pyraclostrobin and chlorothalonil every 14 days. Organic programs, utilizing only biofungicides and organic fertility sources, provided the least amount of control and exceeded the 15% threshold by the second month of the evaluation period.
Management of Chocolate Spot Disease in Faba Bean Plants by using Biological Control Means
Published on: 4th December, 2023
Background: Faba bean (Vicia faba L.) is one of the most important grain legume crops in Egypt and many other countries of the world because the seeds offer a low-cost source of protein, lysine, carbohydrates, minerals, and vitamins. Chocolate spot disease is a stress-related fungal disease produced by Botrytis fabae that causes plant damage, limits photosynthetic activity, and reduces yield. Results: Trichoderma atroviride greatly reduced mycelial growth by 90.00% in vitro, followed by T. harzianum (86.67%) and T. album (83.89%) on average. In vivo, all studied antagonists dramatically reduced Botrytis fabae disease incidence and severity in both seasons 2021/22 and 2022/23. T. atroviride showed the highest efficacy bioagent (73.55 and 85.15%), followed by T. harzianum (72.55 and 81.22%), in controlling B. fabae of faba bean plants in both seasons. In addition, the results also showed that all tested biological treatments had an impact on yield components and increased levels of chlorophyll, protein%, phenols, flavonoids, Peroxidase (PO), polyphenol Oxidase (PPO), chitinase, and -1, 3-glucanase activities compared to control treatment in both seasons. In this regard, spraying T. atroviride showed the highest efficacy as a bioagent, followed by T. harzianum. Contrary, T. hamatum showed the lowest efficacy compared to other treatments in both seasons. Conclusion: This investigation was carried out to determine the effectiveness of several different antagonists, i.e., T. album, T. atrovirde, T. hamatum, and T. harzianum (30 x 106 spore/ml), Blight Stop, and Bio Zeid, for controlling Botrytis fabae on bean plants and evaluating their effect on yield parameters, components, and quality.
Search by University/Institution
Enter your University/Institution to find colleagues at HSPI.
Ensuring author's satisfaction with
- Friendly and hassle-free publication process
- Less production time of articles
- Constructive peer-review
- Enhancing journal reputation
- Regular feedback system
- Quick response to authors' queries
Most Viewed Keywords
- Bilateral trigeminal neuralgia
- Cervical cancer
- Cytomegalovirus
- Critical care nurses
- Lung cancer
- Periprocedural haemoglobin reduction
- Meigs’ syndrome
- Taphonomic study
- Musculoskeletal modeling
- Useful field concepts
- Depression
- Lupus
- Vasculitis: Mastocites
- Vitamin A deficiency
- Spondyloptosis
- Non-communicable disease
- Percutaneous implement extrusion
- Renal Impairment
- Elderly
- Perinatal stress
Search Articles by Country
Get all latest articles in all Heighten Science Publications Inc journals by country.
Testmonials
Congratulations for the excellence of your journal and high quality of its publications.
Angel MARTIN CASTELLANOS
In 2017, I submitted a manuscript to the journal Archives of Biotechnology and Biomedicine belonging to Heighten Science Publications Corporation. Within one week I already received the response from the editor. All processing steps were really fast so in terms of a speedy publication I can particularly recommend the journal Archives of Biotechnology and Biomedicine. The responsible contact person of the journal was always available, which gives a trustworthy impression to the author. Also the peer review process was clear and constructive. So from my experience with Heighten Science Publications Corporation I can recommend publishing there.
University of Tubingen, Germany
Yvonne Mast
Submission of paper was smooth, the review process was fast. I had excellent communication and on time response from the editor.
Ekiti State University Teaching Hospital, Nigeria
Ayokunle Dada
Thank you for your attitude and support. I am sincerely grateful to you and the entire staff of the magazine for the high professionalism and fast quality work. Thank you very much!
USA
Igor Klepikov
"This is my first time publishing with the journal/publisher. I am impressed at the promptness of the publishing staff and the professionalism displayed. Thank you for encouraging young researchers like me!"
Ekiti State University, Nigeria
Adebukola Ajite
Your service is very good and fast reply, also your service understand our situation and support us to publication our articles.
Ayman M Abu Mustafa
The Journal Clinical Nephrology provides a good opportunity for readers to stay updated in the field of clinical nephrology. Additionally - it provides a good opportunity for authors to publish their work. 1. Publication of the accepted manuscripts is sufficiently rapid. 2. The trust factor between the journal and me, as an author, is very important and well preserved. 3. Peer review process very rapid and effective.
Assaf Harofeh Medical Center, Israel
Leonid Feldman
I very much appreciate the humanitarian services provided in my stead by this journal/publisher. It exhibits total absence of editorial impertinence. As an Author, I have been guided to have a fruitful experience. The editorial care is highly commendable.
Chrysanthus Chukwuma
Journal of Pulmonary and Respiratory Research is good journal for respiratory research purposes. It takes 2-3 weeks maximum for review of the manuscript to get published and any corrections to be made in the manuscript. It needs good articles and studies to get publish in the respiratory medicine. I am really glad that this journal editors helped me to get my case report published.
Divya Khanduja
“The choice to submit the forensic case study to the Journal of Addiction Therapy and Research was dictated by the match between the content and the potential readership. The publication process proved to be expedient and we were provided with constructive feedback from reviewers. The final article layout is attractive and conforms to standards. All-in-all, it has been a rewarding process.”
Elisabeth H Wiig
